MedTrace Logo

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

NCT03961217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2135

Last updated 2019-05-28

No results posted yet for this study

Summary

The investigators plan to investigate the consequences of late effects (radiation-induced survivorship syndromes) after radiotherapy in Gynecological and Prostate cancer survivors on return to work (Yes/No) and if RTW happened then time to RTW.

In addition, whether general health, type of work (occupation), work environment factors, individual factors (lifestyle, socioeconomic status etc.), contribute to the adverse late effects of radiotherapy and these Gynecological cancer survivors have a higher risk for disability pension/long term sickness absence (NOT Return to work).

Conditions

  • Gynecologic Cancer
  • Prostate Cancer
  • Radiation Toxicity
  • Malignancy
  • Radiotherapy Side Effect
  • Radiation Injuries
  • Cancer Survivors
  • Radiation Syndrome

Interventions

RADIATION

Radiotherapy

Radiotherapy as part of cancer treatment

Sponsors & Collaborators

  • Vastra Gotaland Region

    collaborator OTHER_GOV

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Gunnar Steineck · Clinical Cancer Epidemiology, Sahlgrenska Academy, Gothenburg, Sweden

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-01-31
Primary Completion
2006-10-31
Completion
2016-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03961217 on ClinicalTrials.gov